Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy von Servy, A., Maubec, E., Sugier, P.E., Grange, F., Mansard, S., Lesimple, T., Marinho, E., Couturaud, B., Girod, A., Albert, S., Dendale, R., Calitchi, E., Sarda, L., Chanal, J., Deschamps, L., Sastre-Garau, X., Laroche, L., Crickx, B., Avril, M.F.

Volltext

Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort von Kandel, M., Allayous, C., Dalle, S., Mortier, L., Dalac, S., Dutriaux, C., Leccia, M.T., Guillot, B., Saiag, P., Lacour, J.P., Legoupil, D., Lesimple, T., Aubin, F., Beylot-Barry, M., Brunet-Possenti, F., Arnault, J.P., Granel-Brocard, F., Stoebner, P.E., Dupuy, A., Maubec, E., Grob, J.J., Dreno, B., Rotolo, F., Ballon, A., Michiels, S., Lebbe, C., Borget, I.

Volltext

Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data von Di Filippo, Y., Dalle, S., Mortier, L., Dereure, O., Dalac, S., Dutriaux, C., Leccia, M.-T., Legoupil, D., Saiag, P., Brunet-Possenti, F., Arnnault, J.-P., Maubec, E., Granel-Brocard, F., De Quatrebarbes, J., Aubin, F., Lesimple, T., Beylot-Barry, M., Stoebner, P.-E., Dupuy, A., Stephan, A., Grob, J.-J., Lefevre, W., Oriano, B., Allayous, C., Lebbé, C., Montaudié, H.

Volltext

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study von Mouriaux, F, Servois, V, Parienti, J J, Lesimple, T, Thyss, A, Dutriaux, C, Neidhart-Berard, E M, Penel, N, Delcambre, C, Peyro Saint Paul, L, Pham, A D, Heutte, N, Piperno-Neumann, S, Joly, F

Volltext

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study von Gutzmer, R, Rivoltini, L, Levchenko, E, Testori, A, Utikal, J, Ascierto, P A, Demidov, L, Grob, J J, Ridolfi, R, Schadendorf, D, Queirolo, P, Santoro, A, Loquai, C, Dreno, B, Hauschild, A, Schultz, E, Lesimple, T P, Vanhoutte, N, Salaun, B, Gillet, M, Jarnjak, S, De Sousa Alves, P M, Louahed, J, Brichard, V G, Lehmann, F F

Volltext

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer von Fumoleau, P., Largillier, R., Clippe, C., Dièras, V., Orfeuvre, H., Lesimple, T., Culine, S., Audhuy, B., Serin, D., Curé, H., Vuillemin, E., Morère, J.-F., Montestruc, F., Mouri, Z., Namer, M.

Volltext

An open-label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib for patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-m... von Saiag, P., Robert, C., Grob, J.J., Mortier, L., Dereure, O., Lebbe, C., Mansard, S., Grange, F., Neidhardt, E.-M., Lesimple, T., Machet, L., Bedane, C., Jeudy, G., Aubin, F., Dreno, B., Szenik, A., Denden, A., Dutriaux, C.

Volltext

Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma von Pracht, M., Mogha, A., Lespagnol, A., Fautrel, A., Mouchet, N., Le Gall, F., Paumier, V., Lefeuvre-Plesse, C., Rioux-Leclerc, N., Mosser, J., Oger, E., Adamski, H., Galibert, M.-D., Lesimple, T.

Volltext

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study von Charton, E., Baldini, C., Fayet, Y., Schultz, E., Auroy, L., Vallier, E., Italiano, A., Robert, M., Coquan, E., Isambert, N., Moreau, P., Touzeau, C., Le Tourneau, C., Ghrieb, Z., Kiladjian, J.-J., Delord, J.-P., Gomez Roca, C., Vey, N., Barlesi, F., Lesimple, T., Penel, N., Soria, J.-C., Massard, C., Besle, S.

Volltext

Concomitant radiotherapy in melanoma brain metastases using the propensity score matching within the French cohort, MelBase von Allayous, C., Oriano, B., Dalle, S., Mortier, L., Leccia, M.-T., Guillot, B., Jeudy, G., Dutriaux, C., Lacour, J.-P., Saiag, P., Brunet-Possenti, F., De Quatrebarbes, J., Stoebner, P.-E., Legoupil, D., Beylot-Barry, M., Lesimple, T., Aubin, F., Ballon, A., Porcher, R., Lebbe, C.

Volltext

Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma von Mignard, C., Deschamps-Huvier, A., Duval-Modeste, A.-B., Dutriaux, C., Khammari, A., Avril, M.-F., Mortier, L., Lesimple, T., Gaudy-Marqueste, C., Lesage, C., Machet, L., Aubin, F., Meyer, N., Beneton Benhard, N., Jeudy, G., Montaudié, H., Arnault, J.-P., Leccia, M.-T., Joly, P., Oncology Research Group Of The French Society Of Dermatology, S.F.D.

Volltext

Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study von Baldini, C., Charton, E., Schultz, E., Auroy, L., Italiano, A., Robert, M., Coquan, E., Isambert, N., Moreau, P., Le Gouill, S., Le Tourneau, C., Ghrieb, Z., Kiladjian, J.J., Delord, J.P., Roca, C. Gomez, Vey, N., Barlesi, F., Lesimple, T., Penel, N., Soria, J.C., Massard, C., Besle, S.

Volltext

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial von Gross-Goupil, M, Fourcade, A, Blot, E, Penel, N, Négrier, S, Culine, S, Chaigneau, L, Lesimple, T, Priou, F, Lortholary, A, Kaminsky, M.C, Provencal, J, Voog, E, Bouzy, J, Laplanche, A, Fizazi, K

Volltext

Leiomyosarcoma of the inferior vena cava von Sulpice, L, Rayar, M, Levi Sandri, G.-B, de Wailly, P, Henno, S, Turner, K, Lesimple, T, Boudjema, K, Meunier, B

Volltext

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil von Negrier, S, Caty, A, Lesimple, T, J-Y, Douillard, Escudier, B, J-F, Rossi, Viens, P, Gomez, F

Volltext

431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cance... von Lokiec, F, Bonneterre, J, Italiano, A, Varga, A, Campone, M, LeSimple, T, Leary, A, Dieras, V, Rezai, K, Giacchetti, S, Proniuk, S, Bexon, A, Gilles, E, Bisaha, J, Zukiwski, A, Cottu, P

Volltext

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma von Long, Georgina V, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Schadendorf, Dirk, Lesimple, Thierry, Plummer, Ruth, Ji, Ran, Zhang, Pingkuan, Mookerjee, Bijoyesh, Legos, Jeff, Kefford, Richard, Dummer, Reinhard, Kirkwood, John M

Volltext

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma von Dummer, Reinhard, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Kirkwood, John M, Chiarion Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Lesimple, Thierry, Plummer, Ruth, Dasgupta, Kohinoor, Gasal, Eduard, Tan, Monique, Long, Georgina V, Schadendorf, Dirk

Volltext

Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvan... von By the French Adjuvant Study Group

Volltext

616 Pimasertib (MSC1936369B/AS703026), a Selective Oral MEK1/2 Inhibitor, Shows Clinical Activity in Melanoma von Delord, J.P, Houédé, N, Awada, A, Lebbe, C, Lesimple, T, Schellens, J.H.M, Rottey, S, Kefford, R, Rejeb, N, Raymond, E

Volltext